Baseline Characteristics of Fabry Disease “Amenable” Migalastat Patients in Argentinian Cohort

Table 1

Distribution of frequencies and correlations for variables “gender,” “age,” “genotype,” “age at diagnosis,” and “age at symptoms onset” classified by “classic” or “late-onset” FD phenotype.

	Classic FD	Late-onset FD	value
Gender (M/F)	3/5	5/4	0.457
Age	43.11 ± 12.4 ys	52.3 ± 14.9 ys	0.180
Genotype	G85D; N34D; M187I; G258V; D264Y	D109G; C174G; N215S; R363H; R212H	—
Age at diagnosis	36.3 ± 12.8 ys	47.40 ± 14.8 ys	0.116
Age of symptoms onset	19.3 ± 13.4 ys	46.6 ± 13.4 ys	0.003

FD: Fabry disease; M: males; F: females; ys: years; statistical significance value.